We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

136 hedge funds and large institutions have $927M invested in Intersect ENT, Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more call options, than puts

Call options by funds: $18.3M | Put options by funds: $2.93M

38% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 40

10% more capital invested

Capital invested by funds: $842M → $927M (+$84.6M)

0% more funds holding

Funds holding: 136136 (0)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
136
Holders Change
Holders Change %
0%
% of All Funds
2.94%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
19
Increased
55
Reduced
40
Closed
19
Calls
$18.3M
Puts
$2.93M
Net Calls
+$15.4M
Net Calls Change
+$8.48M
Name Holding Trade Value Shares
Change
Change in
Stake
SRAM
151
Stone Ridge Asset Management
New York
-$236K -8,374 Closed
CAM
152
ClariVest Asset Management
California
-$153K -5,421 Closed
FQ
153
First Quadrant
California
-$86K -3,040 Closed
SO
154
STRS Ohio
Ohio
-$64K -2,300 Closed
PRC
155
Pearl River Capital
Michigan
-$3K -100 Closed

XENT Hedge Fund Activity: Q1 2019 in Review

136 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2019, worth a combined $927M — up 10% from $842M a quarter earlier.

Fund positioning in XENT was balanced in Q1 2019: 19 funds opened new positions, 19 closed out, 55 added to existing stakes and 40 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $18.6M. The largest seller was Wellington Management Group, cutting an estimated $43M.

  • 136 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $927M of Intersect ENT, Inc stock for Q1 2019, up 10% quarter-over-quarter.
  • 19 funds opened new Intersect ENT, Inc positions in Q1 2019 and 19 closed out, a net change of 0 holders.
  • The largest Intersect ENT, Inc buyer in Q1 2019 was Fidelity Investments, an estimated $18.6M added.
  • The largest Intersect ENT, Inc seller in Q1 2019 was Wellington Management Group, an estimated $43M sold.

Based on aggregated 13F filings for Q1 2019.